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Serine 392 phosphorylation modulates p53
mitochondrial translocation and transcription-
independent apoptosis
Cédric Castrogiovanni1,2, Béranger Waterschoot1,3, Olivier De Backer2,4 and Patrick Dumont*,1,4
The tumor suppressor p53 is a key regulator of apoptosis induced by various cellular stresses. p53 can induce apoptosis by two
mechanisms. First, p53 acts as a transcription factor inducing and repressing pro-apoptotic and anti-apoptotic targets genes,
respectively. Second, p53 is able to translocate to the mitochondria, where it interacts with BCL-2 family members to induce
membrane permeabilization and cytochrome c release. p53 transcriptional activity is regulated by a set of post-translational
modifications that have been well documented. However, how these modifications impact the direct mitochondrial pathway of
death remain poorly understood. In this study, we focused on the role of serine 392 phosphorylation in the control of
p53-dependent apoptosis. We used CRISPR/Cas9 genome editing to substitute serine 392 by a non-phosphorylatable alanine in
HCT-116 colon carcinoma cells. The S392A mutant displayed normal transcriptional activity following genotoxic stress, but
markedly impaired ability to localize to mitochondria. The decreased mitochondrial localization of the S392A mutant correlated
with a lower ability to induce apoptosis. Confirmatory observations were made following enforced expression of the S392A p53
mutant or a phospho-mimetic S392E mutant in H1299 lung carcinoma cells. Our observations support the premise that serine 392
phosphorylation of p53 influences its mitochondrial translocation and transcription-independent apoptotic function.
Cell Death and Differentiation (2018) 25, 190–203; doi:10.1038/cdd.2017.143; published online 22 September 2017
The tumor suppressor p53 occupies a nodal position in
various cellular pathways that preserve the integrity of the
genome in response to a wide variety of stress. Linked to its
ability to induce cell cycle arrest and cell death by apoptosis,
the TP53 gene is found mutated in over 50% of human
cancers.1 Regulation of p53 function is complex, involving
interactions with numerous proteins, localization in different
cell compartments and multiple post-translational modifica-
tions (PTMs) of several types, including phosphorylations.2
The C-terminal phosphorylations of p53 are less studied
than those of its N-terminal region. p53 has at least four
C-terminal serines (S315, S366, S378 and S392) that can be
phosphorylated.3–5 Among these, S392 is highly conserved in
vertebrates. The kinase(s) responsible for S392 phosphoryla-
tion still remain(s) elusive, although several candidates have
been proposed.6–12 The effects of this phosphorylation on p53
activity also remain a matter of debate. S392 phosphorylation
was described to increase the stability of the tumor suppres-
sor, to enhance tetramer formation and to regulate p53 DNA-
binding affinity for specific and non-specific sites.13–15
Evidences also exist that S392 phosphorylation modulates
the capacity of p53 to suppress cell growth and substitution of
mouse S389 to alanine promoted UV-induced skin
tumors.16,17
To study the impact of S392 phosphorylation on p53-
dependent apoptosis, we used the CRISPR/Cas9n technology
to substitute S392 by a non-phosphorylatable alanine in
HCT-116 colon carcinoma cells. We failed to identify a marked
difference in p53 stabilization or transcriptional activity between
cells expressing the S392A mutant and cells harboring wt p53.
Besides its transcriptional activity, p53 has a transcription-
independent function in induction of cell death, based on its
ability to regulate outer mitochondrial membrane (OMM)
permeabilization through interactions with BCL-2 family mem-
bers such as BAX, BAK, BCL-2, and BCL-XL.18–24 Notably,
direct interaction of p53 with BAX and BAK triggers their
oligomerization, leading to OMM permeabilization and release
of apoptotic effectors such as cytochrome c into the
cytosol.22–24 We found that the p53 form phosphorylated on
S392 (P-S392 p53) is enriched in the mitochondrial fraction of
cells exposed to a genotoxic stress. Moreover, the p53 S392A
mutant displays amarkedly impaired ability to translocate to the
OMM and a lower ability to induce apoptosis.
Results
Generation of a HCT-116 cell line expressing the p53
S392A mutant by CRISPR/Cas9n genome edition. Align-
ment of p53 aa sequences of different vertebrate species
highlights the presence of three highly conserved serines
(S15, S215, and S392) (Supplementary Figure S1).
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The impact of S392 phosphorylation on p53 functions
remains a matter of debate. To determine if S392 phosphor-
ylation modulates p53 activity, we substituted S392 by an
alanine in HCT-116 cells by CRISPR/Cas9 genome edition
(Figure 1 and Supplementary Figure S2 for details).25–27
While no clone homozygous for the desired mutation could
be identified, we isolated one clone with a S392A allele and
an allele with a 23 bp deletion, leading to formation of a stop
codon at position 373 (Figure 1a). Western blot analysis of
this clone detected both full-length p53 and a shorter form,
suggesting that the truncated allele (p53 1–372) was
expressed (Figure 1b). As this could interfere with our
observations, we performed a second round of CRISPR/
Cas9n to knockout the truncated allele using sgRNAs guides
targeting codon 40 corresponding to an alternative ATG start
codon (Figure 1a). This procedure allowed to isolate a clone
Figure 1 For caption see page on 192
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with a p53 S392A allele and an allele with a STOP codon in
exon 4, expected to be a null allele (Figures 1a and b). This
clone was called HCT-116 p53 S392A. We also isolated a
clone with an homozygous 8 bp deletion, leading to a
premature STOP codon. This clone expressed no detectable
p53 protein and was considered to be p53 knockout
(Supplementary Figure S3).
To characterize the cell line, we treated p53 S392A+/− and
wt+/+ cellswith 1 μMcamptothecin (CPT) for 24 h.Western blot
analysis with monoclonal DO-1 and polyclonal FL-393 anti-
bodies revealed that both p53 wt and S392A are induced by
CPT. Moreover, no aberrant band was detected in HCT-116
S392A cells using the polyclonal antibody (Figure 1c). Since
S392A cells have only one functional allele, we compared its
p53 protein level with that of wt cells. We performed a semi-
quantitative western blot analysis of cells treated or not with
CPT. The data indicate a significant difference in basal p53 level
between S392A+/− and p53+/+ cells. However, in presence of a
stress, only a non-significant difference of 17% was recorded,
suggesting a minimal impact of one allele knockout on p53
induction in response to a genotoxic stress (Figure 1d).
Additional data on p53 mRNA level in HCT-116 KO, wt and
S392A cells are displayed in Supplementary Figure S4.
HCT-116 p53 S392A cells display reduced apoptosis. We
determined if S392A p53 mutation altered induction of
apoptosis after CPT exposure. HCT-116 p53 KO, wt and
S392A cells were treated with 1 μM CPT for 24 h. Presence of
the caspase-cleaved 89 kDa PARP fragment and expression
of p21waf1 were assessed by western blot. As expected, KO
cells failed to induce p21waf1 expression and PARP cleavage
in response to CPT. Moreover, p21waf1 protein expression
was induced similarly in p53 wt and S392 A cells, while a
decreased PARP cleavage was observed in cells expressing
p53 S392A (Figure 2a). A kinetic of PARP cleavage in
presence of CPT was next performed, indicating a marked
reduction of the level of cleaved PARP at 16 and 24 h in
S392A cells (Figure 2b). We next monitored DNA fragmenta-
tion by flow cytometry analysis of the sub-G1 peak.28 We
found that cells expressing S392A p53 developed signifi-
cantly less apoptosis than their wt counterparts after
treatment with CPT, while KO cells were markedly deficient
for apoptosis induction (Figure 2c). The impact of the S392A
mutation on cell viability was assessed using the trypan blue
dye exclusion method. After a 24 h treatment with CPT, we
recorded an approximatively two-fold reduction of cell death
in S392A cells as compared to wt cells (Figure 2d).
We next investigated the consequences of the S392A
mutation in p53-null H1299 cells. We developed clones with a
tetracycline-inducible expression of wt p53, S392A p53, or
S392E p53, in which S392 was replaced by a glutamic acid,
corresponding to a phospho-mimetic mutation (Figure 2e).
Expression of the different p53 forms was induced by
doxycycline and cells were exposed to CPT. Proliferation was
then determined using a MTS assay. Control cells without p53
were less sensitive to CPT than cells containing any of the p53
forms (Figure 2f). The S392E mutant behaved like wt p53 but
the non-phosphorylable S392Amutant displayed a significantly
reduced sensitivity to CPT (Figure 2f and Supplementary Table
S1 for the detailed statistical analysis). A colony formation
assay further confirmed that failure to phosphorylate S392
compromises p53 tumor suppressor activity (Figure 2g).
The p53 S392A mutant displays normal post-
translational modifications and transcriptional activity
after exposure to CPT. Phosphorylation of S392 was
described to promote p53 binding to DNA.13–15 The impaired
ability of p53 S392A to induce apoptosis could therefore be
linked to an altered transcriptional activity. To test this
hypothesis, we compared the transcriptional activity of
S392A and wt p53 in HCT-116 cells. We determined by RT-
qPCR the levels of transcripts of several target genes whose
promoter have low (BAX and BBC3/PUMA), or high
(CDKN1A, p21waf1) affinity for p53.29,30 After treatments of
4, 8, and 16 h with 1 μM CPT, we observed a marked
induction of the genes encoding for p21waf1 and PUMA in
cells expressing p53 wt or the S392A mutant, as compared to
KO cells (Po0.05). In addition, no significant difference was
found between p53 wt and S392A (Figure 3a). The level of
BAX mRNA was determined after 8 and 16 h of exposure to
CPT. We observed a significant 32% reduction of BAX mRNA
level in cells expressing p53 S392A after 8 h, but not 16 h of
treatment (Figure 3a and Supplementary Table S2). A similar
analysis was performed after 24 h of treatment. At this later
time point, we observed no difference of RNA levels for
p21waf1, BAX, PUMA, PIG3, or BCL-2 (Supplementary
Figure S5). Measure of p21waf1 protein induction by western
blot also suggests an equal ability of both p53 forms to
transactivate CDKN1A (Figure 2a). In addition, S392A and wt
HCT-116 cells showed similar levels of MDM2 after CPT
exposure (Supplementary Figure S6).
Post-translational modifications play a key role in regulating
various aspects of p53 function.2 S46 phosphorylation
promotes transactivation of pro-apoptotic target genes like
Figure 1 Generation of a HCT-116 p53 S392A cell line by CRISPR/Cas9 genome edition. (a) The figure displays a schematic representation of the two p53 alleles and the
modifications introduced. The TP53 gene is composed of 11 exons, the full-length p53 protein being encoded by exons 2–11. S392 is located in the last exon. The repair template
(RT) was correctly introduced in the first allele (allele 1). This allele is functional and allows the expression of p53 S392A. Allele 2 is not functional. In this second allele, partial
insertion of the RTwith a deletion of 23 bases is observed (exon 11). This indel mutation generates a stop codon at position 373. Allele 2 also displays an insertion of 25 bp in exon
4 (after ATG40) that generates a frameshift and formation of a stop codon. Bases in grey represent the silent mutations introduced (near and in the PAM sequence areas
recognized by the two sgRNAs guides). These mutations prevent that the ssODN becomes a substrate for the Cas9n enzyme. (b) Western blot analysis of p53 expression in
HCT-116 p53 wt cells and after each CRISPR step. Western blot analysis after step 1 (targeting of S392) reveals two bands. They correspond to full-length p53 S392A (allele 1)
and the p53 1–372 truncated form (allele 2). After CRISPR step 2 (targeting of ATG40), allele 2 is no more functional as indicated by loss of expression of the truncated 1–372
form. (c) HCT-116 cells expressing p53 wt and the S392A mutant (CRISPR/Cas9n) were treated with 1 μM CPT for 24 h. Total protein extracts were then prepared and p53 levels
were assessed with the anti-p53 DO-1 monoclonal and FL-393 polyclonal antibodies. S392 phosphorylation was also measured. (d) Semi-quantitative western blot analysis for
the expression of total p53 using the ScanLater western blot technology (Molecular Devices). HCT-116 p53 wt and S392A cells were treated or not (NT, no treatment) with 1 μM
CPT for 24 h. Total protein extracts were prepared and detection of p53 was assessed with p53 DO-1 antibody. For the quantification of p53 levels, the signal for p53 was reported
to that of β-actin. The data are means±SD from three independent experiments. Student's t-test was used to calculate significance (*Po0.05; N.S., non-significant)
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PUMA and p53AIP1.31–35 This modification also enhances
p53 mitochondrial translocation.36 In contrast, phosphoryla-
tion of mitochondrial p53 on S315 reduces its association with
BCL-2 and BCL-XL.4 Western blot analysis showed that p53
S392A and wt were similarly phosphorylated on S15, S315
and S46 in cells exposed to CPT (Figure 3b and
Supplementary Figure S7). The acetylation status of the
neighboring K382 was also analyzed. Indeed, acetylations
regulate both p53 transcriptional activity and transcription-
independent functions. For instance, acetylation of K320/373/
382 favors the disruption of a Ku70-BAX complex, promoting
apoptosis.37 We observed that K382 was acetylated in both wt
and S392A cells (Figure 3b and Supplementary Figure S7). In
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similar in HCT-116 cells exposed to CPT (Supplementary
Figure S8).
The p53 form phosphorylated on S392 accumulates after
exposure to CPT. However, the fraction of p53, which is
phosphorylated on S392 decreases with time (Figure 3c).
Thus, in cells exposed to CPT, the level of P-S392 p53
increases more slowly than the total p53 level. This could be
due to a limiting kinase activity. The kinase(s) responsible for
S392 phosphorylation in response to stress is (are) not clearly
identified, but evidences suggest that CK2, CDK9, PKR or p38
MAPK are candidates.6–12 We exposed p53 wt HCT-116 cells
to CPT in the presence of the p38 MAPK inhibitor SB203580
and observed no effect of the inhibitor on S392 phosphoryla-
tion while PARP cleavage was reduced (Figure 3d). We
obtained similar results with H1299 p53wt Tet-On cells treated
for 4 h with or without SB203580 (Figure 3d). We tested the
effect of two other molecules, TBB and Cdk9 Inhibitor II that
inhibit respectively CK2 and CDK9. Both of them failed to
decrease S392 phosphorylation in presence of CPT
(Supplementary Figure S9).
Phosphorylation of S392 promotes p53 mitochondrial
translocation during a genotoxic stress. Since p53
transcriptional activity was not markedly affected by S392
phosphorylation status, we investigated the possibility that
the S392A mutation disturbed p53 mitochondrial transloca-
tion. After 4 and 8 h of exposure to CPT, mitochondrial
fractions were isolated from wt and S392A HCT-116 cells,
and the abundance of p53 was determined by western blot.
The S392A mutant displayed a markedly reduced mitochon-
drial translocation, suggesting that phosphorylation of S392
is an essential step for p53-mediated transcriptional-inde-
pendent signaling, leading to apoptosis in stress condition
(Figure 4a). We next characterized the localization of p53 wt
and its mutants in the H1299 Tet-On clones. We induced p53
expression with doxycycline for 24 h before addition of CPT
for 0, 4 or 16 h. In absence of stress (0 h), the fraction of p53
present in the mitochondrial fraction was higher for the
S392E p53 form than for p53 wt and S392A, suggesting that
S392 phosphorylation enhances mitochondrial localization
(Figure 4b). After 4 or 16 h of exposure to CPT, p53 wt and
the S392E mutant were abundantly present in the
mitochondrial fraction of stressed cells. Comparatively, p53
S392A showed a reduced mitochondrial localization. Of note,
p53 S392A is expressed at a similar level than p53 wt or
S392E, and is present in the cytosolic fraction (Figure 4b).
Similar data were obtained after exposure to a higher CPT
concentration (10 μM rather than 1 μM) (Supplementary
Figure S10).
The S392-phosphorylated form of p53 is enriched in the
mitochondrial fraction of cells exposed to a genotoxic
stress. Since phosphorylation of S392 promotes p53 mito-
chondrial translocation, we next asked whether P-S392 p53
was enriched in the mitochondrial fraction of cells exposed to
apoptotic stimuli. We induced DNA damage to p53 wt
HCT-116 and PA-1 cells by exposure to CPT, doxorubicin
(DOX) or UV-B. The abundance of P-S392 and total p53 was
evaluated by western blot in total protein extracts as well as
mitochondrial and nuclear fractions. We observed that
P-S392 p53 was abundant in the mitochondrial fraction of
the two cell lines while absent from the nuclei (Figure 5). We
also examined additional phosphorylation and acetylation
sites by western blot after a 4 h treatment with DOX. No other
post-translational modification was found to be enriched in
the mitochondrial fraction of both cell lines (Supplementary
Figure S11).
The S392A mutant is not impaired for interactions with
CRM1, GRP75, HSP60 or TID1. Among the numerous
interactions of p53, some regulate its mitochondrial localiza-
tion. The increased mitochondrial localization of the arginine
72 p53 polymorphic variant was previously linked to its
enhanced binding to the E3 ubiquitin ligase MDM2 and
CRM1 (Exportin-1).19 Indeed, interactions that favor p53
nuclear export are also likely to promote its mitochondrial
localization. In addition, S392 phosphorylation could impact
on p53 nuclear export.38 We tested the hypothesis that the
S392A mutation disturbs interaction with CRM1. HCT-116
p53 wt, KO and S392A cells were treated with CPT for 16 h.
Total protein extracts were immunoprecipitated with an anti-
CRM1 antibody and the interaction with p53 was detected by
western blot. We found that p53 S392A was immunopreci-
pitated as efficiently with CRM1 as wt p53 (Figure 6a).
Figure 2 Failure to phosphorylate S392 is correlated with a decreased apoptosis in response to a genotoxic stress. (a) HCT-116 cells expressing p53 wt, the S392A mutant
as well as p53 KO cells were treated or not with 1 μM CPT for 24 h. Total protein extracts were then prepared. PARP cleavage, p53, and p21Waf-1 expression were detected by
western blot analysis. (b) HCT-116 cells expressing p53 wt and S392A were treated with 1 μM CPT for 0, 6, 8, 16, or 24 h. Then, total protein extracts were collected and
measurement of apoptosis induction was assessed by quantification of PARP cleavage. The graph indicates the relative PARP cleavage in the different extracts based on a
densitometry analysis of the band corresponding to cleaved PARP (normalization to β-actin). (c) HCT-116 cells were treated for 24 h with 1 μM CPT. After treatment, cells were
collected, fixed and stained with propidium iodide. The percentage of apoptotic nuclei (sub-G1 population) was evaluated using flow cytometry. Results show the percentage of
apoptotic nuclei in each experimental condition and are the means±S.D. from three independent experiments. Statistical analysis was performed using Student's t-test with
Bonferroni correction (Bonferroni-corrected, *Po0.0253; CPT-treated KO versus p53 wt, Po0.001; CPT-treated S392A versus p53 wt P= 0.003). (d) HCT-116 cells were treated
with 1 μM CPT. After 24 h of treatment, viability was determined by the trypan blue dye exclusion method. Results show the percentage of dead cells in each experimental
condition and are the means±S.D. from three independent experiments. Statistical analysis was performed using Student's t-test with Bonferroni correction (Bonferroni-
corrected, *Po0.0253; KO versus p53 wt, P= 0.0111; S392A versus p53 wt P= 0.0251). (e) Detection of total p53 and its form phosphorylated on S392 in inducible (Tet-On)
H1299 clones expressing p53 wt, S392A and S392E as well as cells transfected with the empty vector. The expression of p53 was induced with 2 μg/ml doxycycline for 24 h. (f)
H1299 Tet-On clones expressing p53 wt, S392A and S392E or transfected with the empty vector were incubated for 72 h with 2 μg/ml doxycycline and increasing concentrations
of CPT (from 0 to 0.2 μM). After treatments, relative cell viability was assessed by a MTS assay. The data are means±S.D. from three independent experiments. The one-way
ANOVA test was used to compare independent groups (for each CPT concentration). When the ANOVA was significant, a Dunnett's test was used to compare a group of interest
with p53 wt as reference (*Po0.05, **Po0.01). Exact P-values and details on the test are available in Supplementary Table S1. (g) Colony formation assay of H1299 Tet-On
clones expressing p53 wt, S392A and S392E or transfected with the empty vector were treated simultaneously with 2 μg/ml of doxycycline and 1 μM of CPT for 3 days
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Moreover, in H1299 cells expressing wt, S392A or S392E
p53, all p53 forms interacted well with CRM1 (Figure 6b).
The chaperones GRP75 (mtHSP70) and HSP60 as well as
the co-chaperone TID1 are known to promote p53
mitochondrial translocation.19,39,40 We hypothesized that
phosphorylation of S392 could facilitate p53 translocation by
enhancing its interaction with one or several of these
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Figure 3 p53 wt and the S392A mutant display similar induction of key p53 target genes and post-translational modifications. (a) Kinetic of the expression level of genes
encoding for p21waf1, PUMA and BAX by RT-qPCR in p53 KO HCT-116 cells and cells expressing p53 wt or S392A. Cells were treated with 1 μM CPT for the indicated times
before RNA extraction. Values are means±S.D. of 3 independent experiments. The one-way ANOVA test was used to compare independent groups (for each CPT
concentration). When the ANOVAwas significant, a Dunnett's test was used to compare a group of interest with p53 wt as reference (*Po0.05). Exact P-values and details on the
test are available in Supplementary table S2. (b) Western blot analysis of different post-translational modifications of p53 after a 24 h treatment of HCT-116 p53 KO, p53 wt and
S392A cells with 1 μM CPT. The primary antibodies used specifically recognized the p53 forms phosphorylated on serines 15, 46, 315 and 392, and the p53 form acetylated on
lysine 382. In parallel, cleavage of PARP was also assessed. (c) Western blot analysis of total p53 and its phosphorylations on S15 and S392 in HCT-116 p53 wt cells treated with
5 μM camptothecin (CPT) for 0, 4 and 16 h. In the left panel, equal amounts of proteins were loaded in each well of the gel, while in the right panel we loaded equivalent amounts
of total p53 at the different time points. (d) In the left panel, HCT-116 p53 wt cells were incubated or not with 20 μM of the p38 MAPK inhibitor SB203580 1 h before addition of
10 μM CPT. After 16 h of treatment, the expression of p53 and its form phosphorylated on S392 as well as PARP cleavage were assessed by western blot analysis. In the right
panel, H1299 Tet-On cells expressing p53 wt received 20 μM of SB203580 1 h before addition of 2 μg/ml doxycycline and 10 μM CPT for 16 h
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Figure 4 S392 phosphorylation promotes p53 mitochondrial translocation in presence of a genotoxic stress. (a) HCT-116 cells expressing p53 wt or the S392A mutant were
treated with 1 μM camptothecin for 4 and 8 h. Total protein extracts as well as mitochondrial fractions were then prepared and screened for the presence of p53. GRP75 is a
mitochondrial protein, while PCNA is both cytosolic and nuclear. Detection of GRP75 and PCNAwas performed to control for the loading and the purity of the fractions. (b) Kinetic
of the mitochondrial relocation of p53 in H1299 Tet-On clones expressing p53 wt, S392A and S392E. H1299 Tet-On clones were incubated overnight with 2 μg/ml doxycycline to
induce p53 expression. The next day, cells were treated with 1 μM CPT for 0, 4 and 16 h. Total protein extracts as well mitochondrial and cytosolic fractions were prepared. The
presence of p53 was characterized by western blot analysis. Detection of GRP75 and PCNAwas performed to control for equal loading of the wells and purity of the fractions. For
the time point 0 h, the densitometry analysis of p53 mitochondrial signals was based on the ratio of the intensities of p53 bands on GRP75 bands
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co-immunoprecipitation experiments in HCT-116 cells expres-
sing p53 wt or S392A. Both p53 forms similarly immunopre-
cipitated with each of the three chaperones, showing that
phosphorylation of S392 is not essential for these interactions
(Figure 6c).
The S392A p53 mutant shows an intact ability to interact
with BCL-2 family members. The tumor suppressor p53
regulates OMM permeabilization through interactions it
establishes with pro- and anti-apoptotic proteins of the BCL-2
family.19–24 In addition, members of this family attached to the
OMM could act as mitochondrial anchors for p53.22,41 The
defective mitochondrial translocation of S392A p53 could
thus be explained by a defective interaction with one or
several BCL-2 family members.
This hypothesis was tested by co-immunoprecipitation in
H1299 cells expressing wt, S392A or S392E p53. After an
overnight induction of p53 with doxycycline followed by a 4 h
treatment with CPT, total extracts were prepared and
analyzed. Regarding the anti-apoptotic proteins BCL-2 and
BCL-XL, no difference of association was observed between
the three p53 forms (Figure 7a). In absence of stress, BAK is
mainly localized at the OMM, but it also associates with the
endoplasmic reticulum membrane.42 Moreover, in certain cell
types, a fraction of BAK is cytosolic.43 We observed that the
three p53 forms co-immunoprecipitated with BAK in total
protein extracts from H1299 cells (Figure 7b). However, when
the immunoprecipitations were performed in isolated mito-
chondrial fractions, S392E and wt p53 displayed a stronger
interaction with BAK as compared to p53 S392A, in
accordance with its defective mitochondrial translocation
(Supplementary Figure S12). Similar results were obtained
in HCT-116 cells exposed to CPT. In the mitochondrial
fractions, less S392A p53/BAK complex than wt p53/BAK
complex was present (Supplementary Figure S13). BAX is
mainly cytosolic in unstressed cells.44 We observed no
P-S392
Total p53










M Nuc Tot M Nuc Tot















M Nuc M Nuc
M Nuc M Nuc
Figure 5 The p53 form phosphorylated on S392 is enriched in the mitochondrial fraction of cells exposed to a genotoxic stress. HCT-116 and PA-1 p53 wt cells were treated
for 4 h with 1 μM doxorubicin or camptothecin. Total protein extracts (Tot) as well mitochondrial (M) and nuclear (Nuc) fractions were prepared thereafter. For UV-B treatment, we
used doses of 400 J/m2 and 100 J/m2 for, respectively, HCT-116 and PA-1 cells. Total protein extracts and fractions were prepared 4 h after the UV-B exposure. For western blot
analysis, we loaded equal amounts of total p53 in each well of the gel. Presence of P-S392 p53 was assessed with a monoclonal antibody that specifically recognizes the p53
form phosphorylated on S392. To control for the purity of the fractions, we detected GRP75 and PCNA
Serine 392 regulates p53 mitochondrial activity
C Castrogiovanni et al
197
Cell Death and Differentiation
difference of association between S392A and wt p53 in total
extracts of H1299 cells exposed to CPT for 4 h (Figure 7c, left
panel). Similar data were obtained when the cells were treated
for 16 h (Supplementary Figure S14). We also analyzed the
BAX-p53 interaction in wt and S392A HCT-116 cells. The
S392Amutant induced BAX expression like wt p53. Moreover,
both p53 forms interacted well with BAX (Figure 7c, right
panel). The sum of these data indicate that S392 phosphor-
ylation status does not influence interactions of p53 with
BCL-2 family members.
Discussion
We observed that a fraction of p53 proteins are constitutively
phosphorylated on S392 and that the abundance of P-S392
p53 markedly increases after exposure to a DNA damaging
agent. However, the fraction of P-S392 p53 molecules
decreases when p53 accumulates in stressed cells
(Figure 8a). This could be explained if the responsible kinase
activity is limiting or if a phosphatase activity increases in
stressed cells. This is in accordance with previously published
reports showing that phosphorylation of S392 is a slow
process and that the short half-life of p53 in unstressed cells
prevents accumulation of P-S392 p53, while in presence of a
stress, the stabilization of p53 allows its accumulation.10,11
To investigate the impact of S392 phosphorylation on p53
function in apoptosis, we substituted S392 by a non-
phosphorylatable alanine in p53 wt HCT-116 cells. We
obtained cells harboring one p53 S392A allele and one p53
knockout allele. These S392A hemizygous cells express p53
protein levels similar to that of p53 wt cells after exposure to
CPT. Interestingly, the p53 S392A cells displayed an
enhanced resistance to the genotoxic agent CPT associated
with a reduced apoptosis as assessed by PARP cleavage and
DNA fragmentation. These observations were recapitulated in
H1299 cells with a tetracycline-inducible expression of wt,
S392A or S392E p53.
The reduced ability of S392A p53 to induce apoptosis after a
genotoxic stress could result from an alteration of its
transcriptional activity. We tested this hypothesis by assessing
the RNA levels of different p53 target genes (p21waf1, BAX,
PUMA, PIG3 and BCL-2) and observed no marked alteration.
This is in line with previous observations showing that the
S392A mutant (or its mouse homologous p53 S389A) was not
affected in its ability to transactivate p21waf1, PUMA or
BAX.45,46 However, other reports indicate that S392
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Figure 6 The S392A mutant is not deficient for different interactions known to modulate p53 mitochondrial translocation. (a) HCT-116 cells expressing p53 wt or the S392A
mutant as well as p53 KO cells were treated with 1 μM CPT for 16 h. Total protein extracts were then prepared and immunoprecipitated with an anti-CRM1 antibody. The
interaction with p53 was detected by western blot. Inputs for p53 and CRM1 in the different extracts are also depicted. (b) H1299 Tet-On clones transfected with the empty vector
as well as cells expressing p53, S392A and S392E were incubated overnight with 2 μg/ml doxycycline to induce p53 expression. The next day, cells were treated with 1 μM CPT
for 4 h. Total protein extracts were next prepared and immunoprecipitated with an anti-CRM1 antibody or control IgG. Detection of p53 was assessed by western blot analysis.
Inputs for p53 and CRM1 in the different extracts are shown. (c) HCT-116 cells expressing p53 wt, the S392A mutant as well as p53 KO cells were treated with 1 μM CPT for 16 h.
Total protein extracts were prepared and immunoprecipitated with anti-GRP75, -HSP60 and -TID1 antibodies. The interaction with p53 was detected by western blot. The inputs
for p53, GRP75, HSP60 and TID1 in the different extracts are depicted
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phosphorylation impacts on the formation of p53 tetramers
and DNA binding.13–15 We thus cannot exclude that subtle
differences exist between the transcriptional activity of wt and
S392A p53.
Independently of its transcriptional activity, p53 also induces
apoptosis by directly triggering OMM permeabilization. This
activity involves its translocation to the mitochondria and
interactions with several BCL-2 family members. How PTMs
impact on p53 mitochondrial activity is still unclear. It has been
evidenced that p53 ubiquitination by MDM2 favors its
mitochondrial translocation.19,47 Sykes and colleagues
showed that p53 acetylation on K120 increased its ability to
release BAK from MCL1.48 Moreover, a fraction of MDMX
resides at the OMM and promotes the recruitment of P-S46
p53.36 We previously showed that S20 phosphorylation is
influential on the p53-BAK interaction and modulates p53
mitochondrial level during late apoptosis.49 More recently,
Zhang et al.50 showed that ubiquitination of cytosolic p53 on
K24 by the TRAF6 E3 ligase inhibits its mitochondrial
translocation and interaction with the BAK-MCL1 complex.50
We show here in two different cell models that failure to
phosphorylate S392 markedly reduces p53 mitochondrial
translocation after exposure to an apoptotic stimulus. We also
found that P-S392 p53 is mainly mitochondrial after a
genotoxic stress. Interestingly, exposure of rat RINm5F
insulinoma cells to high glucose triggers mitochondrial
translocation of P-S390 (homologous to human S392) p53
and presence of P-S390 p53 at the mitochondria correlates
with increased apoptosis.51
Different hypothesis could explain the compromised ability
of S392A p53 to localize to mitochondria. (1) It is possible that
phosphorylation of S392 is required for additional PTMs
necessary to promote mitochondrial translocation. However,
we observed no effect of the S392 mutation on phosphoryla-
tion of S46 or S315, which respectively regulates p53
mitochondrial translocation and association with BCL-2 or
BCL-XL.4,36 (2) p53 might need to interact with a cytosolic
partner in order to be transported to the OMM, as member of a
protein complex. This interaction could be promoted by S392
phosphorylation (Figure 8b). We observed that S392A
mutation does not disturb the interaction of p53 with GRP75,
HSP60 or TID1, which are known to regulate its mitochondrial
translocation.19,39,40 Moreover, S392 phosphorylation status
does not modulate interaction of p53 with BCL-2 family
members. However, it cannot be ruled out that it regulates p53
interaction with a yet unidentified carrier. (3) In another model,
in unstressed cells, p53 would be sequestered in the cytosol
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Figure 7 Phosphorylation of S392 does not modulate p53 interactions with BCL-2 family members. (a) H1299 Tet-On clones transfected with the empty vector as well as cells
expressing p53, S392A and S392E were incubated overnight with 2 μg/ml doxycycline to induce p53 expression. The next day, cells were treated with 1 μM CPT for 4 h. Total
protein extracts were next prepared and immunoprecipitated with anti-BCL-XL and -BCL-2 antibodies. The interaction with p53 was detected by western blot. The inputs for p53,
BCL-XL and BCL-2 in the different extracts are depicted. (b) Immunoprecipitation-western blot analysis of the interaction between p53 and BAK in the H1299 Tet-On clones after a
4 h treatment with CPT. The inputs for p53 and BAK are depicted. (c) Interaction of p53 with BAX in H1299 and HCT-116 cells. In the left panel, H1299 Tet-On clones transfected
with the empty vector as well as cells expressing p53, S392A and S392E were incubated overnight with 2 μg/ml doxycycline to induce p53 expression. The next day, cells were
treated with 1 μM CPT for 4 h. Total protein extracts were next prepared and immunoprecipitated with an anti-BAX antibody. The interaction with p53 was detected by western
blot. In the right panel, HCT-116 cells expressing p53 wt, the S392A mutant as well as p53 KO cells were treated with 1 μM CPT for 4 or 16 h. Total protein extracts were prepared
and immunoprecipitated with an anti-BAX antibody. The interaction with p53 was detected by western blot. The direct immunoprecipitation of BAX and the inputs for p53 and BAX
in the different extracts are also depicted
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through interaction with another protein, and this interaction
would be disrupted by phosphorylation of S392 (Figure 8b).
In summary, we showed that P-S392 p53 is enriched at the
mitochondria after cell exposure to genotoxic agents and that
the S392A non-phosphorylatable p53 mutant displays
impaired mitochondrial translocation and decreased ability to
trigger apoptosis. The exact mechanism by which S392
phosphorylation controls p53mitochondrial localization awaits
further studies. A growing body of evidence now indicates that
several PTMs regulate p53 proapoptotic mitochondrial activity
through modulating its interaction with protein partners, as
described above.4,49–53 Targeting such interactions may
constitute an effective strategy to trigger p53 mitochondrial





































Figure 8 S392 phosphorylation of p53 increases in cells exposed to a genotoxic stress, promoting its mitochondrial localization and apoptosis. (a) In healthy cells, a fraction of
p53 is already phosphorylated on S392. In addition, the S392 phosphorylated form of p53 becomes more abundant after exposure to a genotoxic stress, although accumulation of
P-S392 p53 is poor in comparison to other phosphorylated forms such as P-S15 p53. Therefore, it is likely that, even in cells exposed to an apoptotic stimulus, only a minor
fraction of p53 proteins carries a phosphorylated S392. This post-translational modification modulates the transcription-independent function of p53, P-S392 p53 being
preferentially targeted to the mitochondria. Failure to phosphorylate S392 correlates with a decreased mitochondrial localization of p53 and apoptosis. (b) Hypotheses on the
involvement of S392 phosphorylation in the regulation of p53 trafficking to mitochondria. In the top diagram, we postulate that p53 needs to interact with a cytosolic, yet unknown,
protein partner in order to be translocated to the mitochondria and trigger OMM permeabilization; and that the interaction is facilitated by phosphorylation of S392. In the bottom
diagram, we propose that in the absence of a stress, mitochondrial translocation of cytosolic p53 could be largely prevented through interaction with one or more proteins able to
interact and sequester the tumor suppressor. Moreover, formation of this inhibitory complex is prevented by the increased phosphorylation of serine 392 in cells exposed to a
genotoxic stress, allowing cytosolic p53 to reach the OMM to trigger apoptosis.
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Materials and Methods
Cell culture and treatments. The p53 wt HCT-116 (human colorectal
carcinoma) and PA-1 (human ovarian teratocarcinoma) cell lines were cultured in
DMEM (Lonza, BE12-604 F) supplemented with 10% FBS and 1% penicillin-
streptomycin (Lonza DE17-602E). The p53-null H1299 cell line (ATCC CRL-5803)
was employed to derive Tet-On clones expressing wt p53 or mutants at position
392. Tet-On clones were grown in DMEM supplemented with 10% FBS, 1%
penicillin-streptomycin, 800 μg/ml G418 (Santa Cruz, Dallas, TX, USA, sc-29065)
and 1 μg/ml puromycin (Gibco, A1113803). All cells were tested for mycoplasma
contamination. Camptothecin (Sigma-Aldrich, St Louis, MO, USA, C9911),
doxorubicin (Sigma-Aldrich, D1515) and SB203580 (Cell Signaling, Danvers, MA,
USA, 5633) were used as indicated in the figures. For UV-B treatment, HCT-116
cells were exposed to 400 J/m2 and PA-1 cells to 100 J/m2 (Vilber Lourmat, Marne-
la-Vallée, France, RMX-3 W, France).
Tet-On system. H1299 Tet-On clones were generated by transfection of the
pTet-On vector coding for the transactivator (Clontech, Mountain View, CA, USA)
followed by a second transfection with the pTRE2pur-ΔMyc plasmid containing the
p53 cDNA. The Myc tag was deleted from pTRE2pur-Myc vector (Clontech) using
the BamHI and MluI restriction sites followed by fill-in of 5′overhangs to generate
blunt ends for plasmid ligation. The wt p53 cDNA (R72 polymorphic variant) was
cloned into pTRE2pur-ΔMyc using the EcoRV restriction site. To generate the p53
S392 A and S392E mutants, a site-directed mutagenesis (Agilent Technologies,
Santa Clara, CA, USA) was performed on the p53 wt vector.
CRISPR/Cas9n genome editing. The protocol for genome engineering
using CRISPR/Cas9 is detailed in the works of Feng Zhang and colleagues. We
followed the procedure that utilizes the double nicking mediated by Cas9n
D10A.25,26 Briefly, regions of interest of the TP53 gene from HCT-116 cells were first
sequenced. Sequences were analyzed with the online analysis tools available on
benchling.com to identify and score CRISPR sgRNAs according to their specificity
and efficiency. Sense and anti-sense oligos corresponding to the selected sgRNAs
guides (See Supplementary Table S3 for the sequences) were purchased from
Eurogentec (Liège, Belgium), annealed and cloned into the pSpCas9n(BB)-2A-Puro
PX462 v2.0 vector (Feng Zhang – Addgene 62987). To introduce the desired
mutation into the genome by homologous recombination, we used a synthetic
single-stranded DNA oligonucleotide (ssODN) of 200 bases as repair template. The
ssODN was purchased from Integrated DNA Technologies (Liège, Belgium) (See
Supplementary Table S3 for the sequence). HCT-116 cells were transfected using
Lipofectamin 2000 (Invitrogen, Carlsbad, CA, USA). For one well of a 6-well plate,
the transfection was performed with 1 μg of each pX462 vector coding for the two
guides, with or without 1 μl of 20 μM ssODN. The next day, the transfected cells
were selected with puromycin for 48 h. After 5 days of recovery, a dilution cloning
was performed.
Total protein extracts. Proteins were extracted with NP40 lysis buffer (50 mM
Tris-HCl pH 8, 150 mM NaCl, 5 mM EDTA, 1% NP40) supplemented with protease
(Thermofisher, Waltham, MA, USA, 78429) and phosphatase inhibitors (Phospha-
tase Inhibitor cocktails 2 and 3, Sigma-Aldrich P5726 and P0044).
Mitochondria isolation. Cells were scraped and centrifuged at 500 g. After
two washes in PBS, the pellet was resuspended in fractionation buffer (10 mM
Hepes pH 7.4, 300 mM Mannitol, 1 mM EDTA, 0.2 mM EGTA) supplemented with
protease and phosphatase inhibitors. The cell suspension was lysed with a pre-
chilled type B Dounce homogenizer. To remove intact cells, cell debris, lysed
membrane and nuclei, the lysate was centrifuged 3 times at 500 g (10 min, 4 °C).
The supernatant from the last centrifugation was collected and centrifuged at
9000 × g (10 min, 4 °C). After centrifugation, the supernatant (cytosolic fraction) was
stored at − 20 °C. The pellet (mitochondrial fraction) was resuspended in 100 μl of
fractionation buffer and stored at − 20 °C overnight for complete lysis of
mitochondria.
Isolation of nuclear extracts. Cells were scraped and centrifuged at 500 g.
After two washes with PBS, the pellet was resuspended in hypotonic buffer (10 mM
Hepes-NaOH pH 7.9, 0.1 mM EDTA, 10 mM KCl) supplemented with 1 mM DTTas
well as protease and phosphatase inhibitors. After a 15 min incubation on ice, cells
were lyzed with a type B Dounce homogenizer and centrifuged at 4000 × g for 2 min
at 4 °C. The pellet was washed with hypotonic buffer and after a second
centrifugation, it was resuspended in hypertonic buffer (20 mM Hepes-KOH pH 7.9,
400 mM NaCl, 1 mM EDTA, 20% Glycerol) supplemented with 1 mM DTTas well as
protease and phosphatase inhibitors. After a 45 min incubation on ice with brief
vortexing every 5–10 min, the suspension was centrifuged at 14 000 g for 5 min at
4 °C and the supernatant (soluble nuclear fraction) was collected.
Western blot. Protein concentrations were determined using the BCA Protein
Assay (Thermofisher, 23225). Equal amounts of protein were separated on SDS-
polyacrylamide gels and transferred to PVDF membrane. Membranes were blocked
with 5% non-fat dry milk or alternatively 5% BSA in PBS or containing 0.2% Tween-
20 (PBS-T) for 30 min. After blocking, the membrane was incubated with the
primary antibody 1 h at room temperature or overnight at 4 °C. Next, the membrane
was washed three times with PBS-T and incubated 1 h with the appropriate
peroxidase-conjugated secondary antibody (1:5,000 dilution; Dako). After three
washes, the immunoreactive bands were detected using the Western Lightning
Plus-ECL kit (PerkinElmer, Waltham, MA, USA). For detection of phospho-specific
residues of p53, the proteins were transferred to a nitrocellulose membrane and we
used TBS-T (0.1% Tween-20) during the incubation and the washes. The following
primary antibodies were used: mouse anti-actin Ab (Sigma-Aldrich, A1978), mouse
anti-cleaved PARP (Asp214) Ab (Cell Signaling, 9546), mouse anti-p53 (DO-1) Ab
(Millipore, Billerica, MA, USA, OP43), rabbit anti-p53 (FL-393) Ab (Santa Cruz, sc-
6243), mouse anti-p21 Ab (Cell Signaling, 2946), rabbit anti-p53 P-Ser15 Ab (Cell
Signaling, 9284), rabbit anti-p53 P-Ser46 Ab (Cell Signaling, 2521), rabbit anti-p53
P-Ser315 Ab (Cell Signaling, 2528), rabbit anti-p53 P-Ser392 Ab (Cell Signaling,
9281), rabbit anti-p53 Acetyl-Lys382 Ab (Cell Signaling, 2525), mouse anti-PCNA
Ab (Santa Cruz, sc-56), goat anti-GRP75 Ab (Santa Cruz, sc-1058), rabbit anti-
HSP60 Ab (Santa Cruz, sc-1722), mouse anti-TID1 Ab (Santa Cruz, sc-18820) and
rabbit anti-CRM1 Ab (Santa Cruz, sc-5595), rabbit anti-BAK (NT) Ab (Millipore, 06-
536), mouse anti-Bcl-2 (Clone 7) Ab (BD Biosciences, Franklin Lakes, NJ, USA,
610539), mouse anti-Bcl-xL (7B2.5) Ab (Santa Cruz, sc-56021), rabbit Anti-Bax
(NT) Ab (Millipore, ABC11). To perform semi-quantitative WB analysis, we used the
ScanLater Western Blot Detection Cartridge in a SpectraMax® i3 microplate reader
system (Molecular Devices, Sunnyvale, CA, USA) according to manufacturer’s
instructions. After transfer of proteins to PVDF membranes and blocking, the
membrane was incubated simultaneously with the anti-p53 DO-1 and anti-actin
antibodies. After 3 washes, the membrane was incubated with a secondary
Europium-labeled anti-mouse antibody (Molecular Devices, R8205). Immunoreac-
tive bands were scanned using the SpectraMax i3 microplate reader system and
analyzed with the integrated software.
MTS assay. Cells seeded in 96-well plates (5,000 cells/well) were treated for
72 h as described in the figures. After treatment, cells were incubated for 1 h in
fresh culture medium supplemented with a solution of MTS/PMS (Promega,
Madison, WI, USA; G5421) according to manufacturer’s instructions. After the
incubation, global cell growth was assessed by measuring the absorbance at 490
nm directly proportional to the number of live cells.
RNA extraction and quantitative RT-PCR analysis. Cells from one
100 mm round culture dish were lysed directly into Ribozol reagent (Amresco,
Solon, OH, USA). The upper aqueous phase was collected, treated with DNAse and
purified with the RNeasy Mini Kit (Qiagen, Hilden, Germany) according to
manufacturer’s instructions. The purified RNAs were reverse transcribed using the
GoScript Reverse Transcription System (Promega) with 1 μg of total RNA and a mix
of 0.5 μg of random and Oligo(dT) primers. After the RT-reaction, the samples were
diluted four-fold. Quantitative PCR of mRNA levels were performed in triplicate on a
StepOne+ (Applied Biosystems, USA) using SYBR Green dye (with ROX dye as
reference) as detection method (Thermofisher, K0221). Detection of GAPDH mRNA
level was run in parallel to the genes of interest. The primers used during the
quantitative RT-PCR analysis are listed in Supplementary Table S4.54–58
Cell viability measurement using trypan blue. Cells were treated as
described in the figures. After treatment, the culture medium containing dead cells
was collected and the adherent cells were trypsinized. Trypsin was neutralized with
the collected medium. Cell viability was assessed directly on the cell suspension
with the trypan blue dye exclusion method (Vi-CELL Cell Counter automate,
Beckman, USA).
Co-immunoprecipitation. Cells were lysed in NP40 lysis buffer (50 mM Tris-
HCl pH 8, 150 mM NaCl, 1% NP40). Alternatively, for CRM1 immunoprecipitation,
cells were lysed in high-salt lysis buffer (50 mM Tris-HCl pH 8, 300 mM NaCl, 5 mM
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EDTA, 1% NP40). Buffers were supplemented with protease and phosphatase
inhibitors. After lysis, 800 μl to 2 ml of buffer containing 300 μg (for CRM1 IP),
500 μg (for GRP75, HSP60 and BAK IPs) or 2 mg (for BCL-2, BCL-XL and BAX
IPs) of proteins were incubated with 1 to 2 μg of the adequate antibody for 2 h to
overnight at 4 °C. Protein complexes were immunoprecipitated with 20 μl of agarose
protein G slurry (Pierce, 20398) for 30 min at 4 °C, followed by an incubation of
30 min at room temperature. The beads were washes four times with 700 μl of
NP40 (or high-salt) lysis buffer. Protein complexes were eluted with 20 μl of 1 ×
Laemmli sample buffer and analyzed by western blot. Western blot detection of the
primary antibody was performed with HRP Anti‑Light Chain-Specific Antibodies
(Jackson Laboratories, Bar Harbor, ME, USA) or with HRP anti-IgG conformation
specific (TrueBlot anti-Rabbit IgG HRP and TrueBlot ULTRA anti-Mouse IgG HRP
(Rockland, Pottstown, PA, USA)).
Sub-G1 peak analysis by flow cytometry. The protocol followed has
been described in details by C. Riccardi and I. Nicoletti.28 Briefly, after treatment,
cells were washed with PBS, resuspended in 70% EtOH and stored at − 20 °C. On
the day of the analysis, cells were washed with PBS and resuspended in 1 ml of
DNA staining solution containing 20 μg of propidium iodide and 0.2 mg of DNase
free RNase per mL of PBS. After 30 min of incubation in the dark, analysis of the
sub-G1 peak was performed cells on a Guava easyCyte 6HT-2 L flow cytometer
(Millipore, USA).
Colony formation assay. Cells were treated as described in the figure. After
treatment, the cells were washed twice with PBS and fixed with 4% formaldehyde
for 15 min. After 2 washes with PBS, cells were stained with 0.03% crystal violet for
20 min at room temperature. The stained colonies were washed twice with PBS and
once with deionized water. Next, the plates were air dried.
Statistical analyses. The statistical analysis was performed using the JMP
Pro v.12.1.0 software (SAS Institute, Cary, NC, USA). The statistical tests employed
are described in the figure legends.
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